Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000903423-01-500110
Filing Date
2001-05-23
Accepted
2001-05-23 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 icndfan5-23.txt DFAN14A 10735
  Complete submission text file 0000903423-01-500110.txt   12517
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
ICN PHARMACEUTICALS INC (Subject) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-11397 | Film No.: 1646589
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 730 FIFTH AVENUE NEW YORK NY 10019
ICN COMMITTEE TO MAXIMIZE SHAREHOLDER VALUE (Filed by) CIK: 0001137668 (see all company filings)